The Safety and Effectiveness of CVA-FLOW Software Device for Acute Ischemic Stroke
- Conditions
- StrokeStroke, AcuteStroke, IschemicStroke HemorrhagicStroke, Cardiovascular
- Interventions
- Diagnostic Test: CVAid Flow
- Registration Number
- NCT05745051
- Lead Sponsor
- Cvaid Medical
- Brief Summary
The purpose of this study is to demonstrate the effectiveness and safety of CVA-FLOW, a digital health AI based Telestroke system developed by CVAID Ltd. Company aims to assist certified medical staff to triage acute ischemic stroke patients using dedicated algorithms in order to support application for market approval for CVA-FLOW device.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
- Suspected hyper-acute stroke patient at the ED, prior to treatment (tPA or EVT)
- Age≥18
- Intubated patients upon arrival
- Time from stroke symptoms onset > 24h
- Patients post treatment (tPA of EVT)
- Patient in acute psychosis state
- Patients who do not speak Hebrew as their mother tongue
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Evaluate the safety and effectiveness of CVA-FLOW Software Device for acute ischemic stroke CVAid Flow The purpose of this study is to demonstrate the effectiveness and safety of CVA-FLOW, a digital health AI based Telestroke system developed by CVAID Ltd. Company aims to assist certified medical staff to triage acute ischemic stroke patients using dedicated algorithms in order to support application for market approval for CVA-FLOW device.
- Primary Outcome Measures
Name Time Method Sensitivity and specificity of stroke severity classification by CVA-CORE algorithm after 24 hours Stroke severity classification will be calculated by the CVA-CORE system algorithm and compared to the imaging results (interpretation).
- Secondary Outcome Measures
Name Time Method Device operational performance after 24 hours The investigator shall assess the use of the device during the operation, and conclude a summary evaluation after the end of the usage. Evaluation items are shown below:Item / evaluation
* Usage experience: Simple to operate/difficult to operate
* Errors: No errors occurs during the usage/ Errors occurs during the usage
* Known safety issues during use of CVA-MED and CVA-COLLECTOR
Trial Locations
- Locations (1)
Shaare Zedek Medical Center
🇮🇱Jerusalem, Israel